Indeed, one population-based study demonstrated a positive trend in the use of SRS in 14,722 patients with BM from SCLC identified from the US NCDB covering the period of 2004–2013; the increase of the SRS use from 2.7% in 2004 to 4.3% in 2013 was observed.
← all excerpts
Radiotherapy for brain metastases from small-cell lung cancer in distinct clinical indications and scenarios.
1
—
—